These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 8769201

  • 21. Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups.
    Keown PA.
    Transplant Proc; 1996 Aug; 28(4):2147-50. PubMed ID: 8769183
    [Abstract] [Full Text] [Related]

  • 22. Experience with clinical use of Sandimmun Neoral in renal transplant patients.
    Min ZL, Zhao M, Zhu YH, Qi J, Wang LM, Wang YW.
    Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692
    [No Abstract] [Full Text] [Related]

  • 23. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 24. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA.
    Transplantation; 1998 Jun 15; 65(11):1455-60. PubMed ID: 9645802
    [Abstract] [Full Text] [Related]

  • 25. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug 15; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 26. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
    Qazi YA, Forrest A, Tornatore K, Venuto RC.
    Clin Transplant; 2006 Aug 15; 20(3):313-7. PubMed ID: 16824147
    [Abstract] [Full Text] [Related]

  • 27. Safety and tolerability of Neoral in transplant recipients.
    Feutren G, Wong R, Jin J, Niese D, Mellein B.
    Transplant Proc; 1996 Aug 15; 28(4):2177-82. PubMed ID: 8769193
    [No Abstract] [Full Text] [Related]

  • 28. Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral.
    Al Wakeel JS, Shaheen FA, Mathew MC, Abouzeinab HM, Al Alfi A, Tarif NM, Al Mousawi MS, Mahmoud TS, Alorrayed AS, Fagir EA, Dham RS, Shaker DS.
    Transplant Proc; 2008 Sep 15; 40(7):2252-7. PubMed ID: 18790206
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A, Lee WT, Jacob E, Woo KT.
    Transplant Proc; 1996 Jun 15; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract] [Full Text] [Related]

  • 30. Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.
    Chu SH, Pang ST, Chiang YJ, Chuang CK, Chen HW, Chen CS, Chou CC, Huang CC.
    Transplant Proc; 1998 Nov 15; 30(7):3521-3. PubMed ID: 9838543
    [No Abstract] [Full Text] [Related]

  • 31. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
    Anderson IF, Helve T, Hannonen P, Leirisalo-Repo M, Gilboe IM, Nissilä M, Keystone EC, Kraag GR, Bjørneboe O, Chalmers A, Dovland H, Mueller E, Richard F, Whatmough I, Schmidt AG, Kovarik JM.
    J Rheumatol; 1999 Mar 15; 26(3):556-62. PubMed ID: 10090162
    [Abstract] [Full Text] [Related]

  • 32. An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients.
    Park K, Koh YB, Kwak JY, Kim SJ, Yoon YS, Kang CM, Kim YS.
    Transplant Proc; 1996 Jun 15; 28(3):1202-3. PubMed ID: 8658627
    [No Abstract] [Full Text] [Related]

  • 33. Case study: de novo application of Neoral in renal transplantation.
    Kahan BD.
    Transplant Proc; 1996 Aug 15; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196
    [No Abstract] [Full Text] [Related]

  • 34. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M, Satta R, Branca GF, Pala PG, Serra G, Satta RP, Sorba G.
    Transplant Proc; 1998 Aug 15; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract] [Full Text] [Related]

  • 35. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.
    Transplantation; 1998 Dec 27; 66(12):1632-40. PubMed ID: 9884251
    [Abstract] [Full Text] [Related]

  • 36. Economic analysis of Neoral in de novo renal transplant patients in Canada.
    Kingma I, Ludwin D, Dandavino R, Wolff JL, Loertscher R, Beauregard-Zollinger L, Bacquet P, Boucher S, Rivière M.
    Clin Transplant; 1997 Feb 27; 11(1):42-8. PubMed ID: 9067694
    [Abstract] [Full Text] [Related]

  • 37. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H, Abrams B, Bleehen SS, Bräutigam M, Burrows D, Ettelt MJ, Fry L, Happle R, Haustein UF, Ganslandt J, Jung EG, Knop J, Kühne KH, Mellein B, Mørk NJ, Rogers S, Schmidt AG, Schopf RE, Sumner M, Taube KM, Weidinger G, Wurdel C, Zahn E.
    Dermatology; 1998 Feb 27; 196(2):231-6. PubMed ID: 9568413
    [Abstract] [Full Text] [Related]

  • 38. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N, Erdem C.
    J Eur Acad Dermatol Venereol; 1998 Nov 27; 11(3):240-6. PubMed ID: 9883436
    [Abstract] [Full Text] [Related]

  • 39. Case reports on conversion to Neoral therapy in renal transplant patients.
    Curtis JJ.
    Transplant Proc; 1996 Aug 27; 28(4):2221-2; discussion 2218. PubMed ID: 8769205
    [No Abstract] [Full Text] [Related]

  • 40. Oral cyclosporine preparations immediately following renal transplantation.
    Katz SM, Amante A, Schoenberg L, Kahan BD.
    Transplant Proc; 1996 Aug 27; 28(4):2164. PubMed ID: 8769188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.